Serum lipids, lipoprotein lipids and coronary heart disease in patients with xanthelasma palpebrarum. 1981

A Watanabe, and A Yoshimura, and T Wakasugi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and J Koizumi, and S Ito, and M Ohta, and S Miyamoto, and H Mabuchi, and R Takeda

Serum lipids and lipoprotein lipids were studied in 53 patients (21 males and 32 females) with xanthelasma palpebrarum and 40 age-matched normal controls (20 males and 20 females). Patients were subdivided into patients with normolipidemia, hyperlipidemia or familial hypercholesterolemia (FH). In both male and female patients with hyperlipidemia or FH, the serum cholesterol (Chol) levels were significantly higher than in normal controls. In both male and female patients with normolipidemia or hyperlipidemia, the VLDL-Chol levels were significantly higher than in normal controls. Male patients with FH showed significantly higher levels of VLDL-Chol than normal controls. Both male and female patients with normolipidemia, hyperlipidemia or FH showed significantly higher levels of LDL-Chol, lower HDL-Chol levels and lower HDL-Chol/LDL-Chol ratios than normal controls. In both male and female patients with hyperlipidemia and in male patients with FH, the serum triglyceride (TG) levels were significantly higher than in normal controls. Both male and female hyperlipidemic patients showed significantly higher levels of VLDL-TG than normal controls. In male patients with FH, the VLDL-TG levels were significantly above the control levels. In male patients with normolipidermia, the LDL-TG levels were significantly higher than in normal controls. In both male and female patients with hyperlipidemia or FH, the LDL-TG levels were significantly higher than in normal controls. The HDL-TG levels in patients with normolipidemia (males) or FH (females) were significantly lower than in normal controls. The prevalence of coronary heart disease in patients with normolipidemia, hyperlipidemia or FH was 29.4%, 24.0% and 45.4%, respectively.

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Watanabe, and A Yoshimura, and T Wakasugi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and J Koizumi, and S Ito, and M Ohta, and S Miyamoto, and H Mabuchi, and R Takeda
January 1971, British medical journal,
A Watanabe, and A Yoshimura, and T Wakasugi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and J Koizumi, and S Ito, and M Ohta, and S Miyamoto, and H Mabuchi, and R Takeda
January 2016, Anais brasileiros de dermatologia,
A Watanabe, and A Yoshimura, and T Wakasugi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and J Koizumi, and S Ito, and M Ohta, and S Miyamoto, and H Mabuchi, and R Takeda
January 2004, International ophthalmology,
A Watanabe, and A Yoshimura, and T Wakasugi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and J Koizumi, and S Ito, and M Ohta, and S Miyamoto, and H Mabuchi, and R Takeda
March 2020, Journal of the American Academy of Dermatology,
A Watanabe, and A Yoshimura, and T Wakasugi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and J Koizumi, and S Ito, and M Ohta, and S Miyamoto, and H Mabuchi, and R Takeda
July 1981, Casopis lekaru ceskych,
A Watanabe, and A Yoshimura, and T Wakasugi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and J Koizumi, and S Ito, and M Ohta, and S Miyamoto, and H Mabuchi, and R Takeda
February 1984, Orvosi hetilap,
A Watanabe, and A Yoshimura, and T Wakasugi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and J Koizumi, and S Ito, and M Ohta, and S Miyamoto, and H Mabuchi, and R Takeda
February 2002, Journal of internal medicine,
A Watanabe, and A Yoshimura, and T Wakasugi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and J Koizumi, and S Ito, and M Ohta, and S Miyamoto, and H Mabuchi, and R Takeda
July 1948, British medical journal,
A Watanabe, and A Yoshimura, and T Wakasugi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and J Koizumi, and S Ito, and M Ohta, and S Miyamoto, and H Mabuchi, and R Takeda
January 1953, Acta ophthalmologica,
A Watanabe, and A Yoshimura, and T Wakasugi, and R Tatami, and K Ueda, and R Ueda, and T Haba, and T Kametani, and J Koizumi, and S Ito, and M Ohta, and S Miyamoto, and H Mabuchi, and R Takeda
August 2008, International journal of dermatology,
Copied contents to your clipboard!